Evidence map›Paper›PMID 24752751›Full record

ArticleEuropean journal of immunology2014

Altered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.

LeShara M Fulton, Nicholas A Taylor, James M Coghill, Michelle L West, Niko Föger, James E Bear, Albert S Baldwin, Angela Panoskaltsis-Mortari, Jonathan S Serody

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

LeShara M FultonDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA.
Nicholas A Taylor
James M Coghill
Michelle L West
Niko Föger
James E Bear
Albert S Baldwin
Angela Panoskaltsis-Mortari
Jonathan S Serody
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer CenterResearch Center Borstel - Leibniz Lung Center · DEUniversity of Minnesota Medical Center · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM008719 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DARVILLE, TONI, DESHMUKH, MOHANISH P · 1999 to 2023
$15.1M
Treg Migration in GVHDR01AI064363 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2005 to 2009
$2.0M
Th1/Th17 Macrophage Interactions in Cutaneous GVHDR01CA166794 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2012 to 2016
$1.5M
Targeting CCR7 for the Prevention/Treatment of GvHDR01HL115761 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2012 to 2015
$1.4M
The Coordination of Cytoskeletal Dynamics by CoroninsR01GM083035 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BEAR, JAMES E · 2007 to 2011
$1.2M
Treg Migration in GVHDR56AI064363 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SERODY, JONATHAN S. · 2011 to 2011
$420k
Immunotherapy of the Basal-llike and Claudin-Low Intrinsic Breast Cancer SubtypesF31CA183556 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TAYLOR, NICHOLAS · 2013 to 2015
$92k
Regulation of Acute Graft-versus-Host Disease by CoroninsF31AI096900 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FULTON, LESHARA MALIKA · 2011 to 2013
$64k
NCI NIH HHS 5F31CA183556-02NCI NIH HHS F31 CA183556NCI NIH HHS P30 CA016086NCI NIH HHS R01 CA166794NHLBI NIH HHS R01 HL115761NIAID NIH HHS 5F31AI096900-02NIAID NIH HHS F31 AI096900NIAID NIH HHS R01 AI064363NIAID NIH HHS R56 AI064363NIGMS NIH HHS R01 GM083035NIGMS NIH HHS T32 GM008719
6 · The paper itself

Abstract

Acute graft-versus-host disease (aGvHD) is a major limitation to the use of allogeneic stem cell transplantation for the treatment of patients with relapsed malignant disease. Previous work using animals lacking secondary lymphoid tissue (SLT) suggested that activation of donor T cells in SLT is critically important for the pathogenesis of aGvHD. However, these studies did not determine if impaired migration into, and more importantly, out of SLT, would ameliorate aGvHD. Here, we show that T cells from mice lacking Coronin 1A (Coro 1A(-/-)), an actin-associated protein shown to be important for thymocyte egress, do not mediate acute GvHD. The attenuation of aGvHD was associated with decreased expression of the critical trafficking proteins C-C chemokines receptor type 7 (CCR7) and sphingosine 1 phosphate receptor on donor T cells. This was mediated in part by impaired activation of the canonical NF-κB pathway in the absence of Coro 1A. As a result of these alterations, donor T cells from Coro 1A(-/-) mice were not able to initially traffic to SLT or exit SLT after BM transplantation. However, this alteration did not abrogate the graft-versus-leukemia response. Our data suggest that blocking T-cell migration into and out of SLT is a valid approach to prevent aGvHD.

Indexed as

Bone Marrow TransplantationAcute DiseaseAllograftsAnimalsCell MovementGraft vs Host DiseaseMiceMice, Inbred BALB CMice, KnockoutMicrofilament ProteinsNF-kappa BReceptors, CCR7Receptors, LysosphingolipidSphingosine-1-Phosphate ReceptorsT-LymphocytesCcr7 protein, mousecoronin proteinsMicrofilament ProteinsNF-kappa BReceptors, CCR7Receptors, LysosphingolipidS1pr1 protein, mouseSphingosine-1-Phosphate ReceptorsCoroninGraft-versus-host diseaseT cellsTransplantation

Identifiers

PMID24752751
PMCPMC4083456
OpenAlexW1589459265

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.